413 related articles for article (PubMed ID: 10444309)
1. The effect of growth hormone secretagogues and neuropeptide Y on hypothalamic hormone release from acute rat hypothalamic explants.
Korbonits M; Little JA; Forsling ML; Tringali G; Costa A; Navarra P; Trainer PJ; Grossman AB
J Neuroendocrinol; 1999 Jul; 11(7):521-8. PubMed ID: 10444309
[TBL] [Abstract][Full Text] [Related]
2. The hypothalamic mechanisms of the hypophysiotropic action of ghrelin.
Wren AM; Small CJ; Fribbens CV; Neary NM; Ward HL; Seal LJ; Ghatei MA; Bloom SR
Neuroendocrinology; 2002 Nov; 76(5):316-24. PubMed ID: 12457042
[TBL] [Abstract][Full Text] [Related]
3. The growth hormone secretagogue hexarelin stimulates the hypothalamo-pituitary-adrenal axis via arginine vasopressin.
Korbonits M; Kaltsas G; Perry LA; Putignano P; Grossman AB; Besser GM; Trainer PJ
J Clin Endocrinol Metab; 1999 Jul; 84(7):2489-95. PubMed ID: 10404825
[TBL] [Abstract][Full Text] [Related]
4. The effects of ghrelin/GHSs on AVP mRNA expression and release in cultured hypothalamic cells in rats.
Nemoto T; Sugihara H; Mano A; Kano T; Shibasaki T
Peptides; 2011 Jun; 32(6):1281-8. PubMed ID: 21514337
[TBL] [Abstract][Full Text] [Related]
5. GH and cortisol rebound rise during and following a somatostatin infusion: studies in dogs with the use of a GH-releasing peptide.
Rigamonti AE; Bonomo SM; Cella SG; Müller EE
J Endocrinol; 2002 Sep; 174(3):387-94. PubMed ID: 12208658
[TBL] [Abstract][Full Text] [Related]
6. Activation of the hypothalamo-pituitary-adrenal axis by the growth hormone (GH) secretagogue, GH-releasing peptide-6, in rats.
Thomas GB; Fairhall KM; Robinson IC
Endocrinology; 1997 Apr; 138(4):1585-91. PubMed ID: 9075719
[TBL] [Abstract][Full Text] [Related]
7. Interaction of the growth hormone releasing peptide hexarelin with somatostatin.
Massoud AF; Hindmarsh PC; Brook CG
Clin Endocrinol (Oxf); 1997 Nov; 47(5):537-47. PubMed ID: 9425393
[TBL] [Abstract][Full Text] [Related]
8. Ghrelin is released from rat hypothalamic explants and stimulates corticotrophin-releasing hormone and arginine-vasopressin.
Mozid AM; Tringali G; Forsling ML; Hendricks MS; Ajodha S; Edwards R; Navarra P; Grossman AB; Korbonits M
Horm Metab Res; 2003 Aug; 35(8):455-9. PubMed ID: 12953161
[TBL] [Abstract][Full Text] [Related]
9. Interactions of growth hormone secretagogues and growth hormone-releasing hormone/somatostatin.
Tannenbaum GS; Bowers CY
Endocrine; 2001 Feb; 14(1):21-7. PubMed ID: 11322498
[TBL] [Abstract][Full Text] [Related]
10. The central effects of orexin-A in the hypothalamic-pituitary-adrenal axis in vivo and in vitro in male rats.
Russell SH; Small CJ; Dakin CL; Abbott CR; Morgan DG; Ghatei MA; Bloom SR
J Neuroendocrinol; 2001 Jun; 13(6):561-6. PubMed ID: 11412343
[TBL] [Abstract][Full Text] [Related]
11. Expression analysis of hypothalamic and pituitary components of the growth hormone axis in fasted and streptozotocin-treated neuropeptide Y (NPY)-intact (NPY+/+) and NPY-knockout (NPY-/-) mice.
Park S; Peng XD; Frohman LA; Kineman RD
Neuroendocrinology; 2005; 81(6):360-71. PubMed ID: 16244497
[TBL] [Abstract][Full Text] [Related]
12. Hexarelin, a novel GHRP-6 analog, stimulates growth hormone (GH) release in a GH-secreting rat cell line (GH1) insensitive to GH-releasing hormone.
Giustina A; Bonfanti C; Licini M; Ragni G; Stefana B
Regul Pept; 1997 May; 70(1):49-54. PubMed ID: 9250581
[TBL] [Abstract][Full Text] [Related]
13. Hexarelin, a synthetic growth-hormone releasing peptide, shows no interaction with corticotropin-releasing hormone and vasopressin on adrenocorticotropin and cortisol secretion in humans.
Arvat E; Maccagno B; Ramunni J; Di Vito L; Broglio F; Deghenghi R; Camanni F; Ghigo E
Neuroendocrinology; 1997 Dec; 66(6):432-8. PubMed ID: 9430449
[TBL] [Abstract][Full Text] [Related]
14. [The effects of PGE2, 2-DG and L-arginine on hypothalamic GHRH and SRIF releases in conscious rats, with respect to GH secretion].
Kimura S; Kameyama K; Hosoi E; Saito S
Nihon Naibunpi Gakkai Zasshi; 1989 Feb; 65(2):113-27. PubMed ID: 2568278
[TBL] [Abstract][Full Text] [Related]
15. Pituitary responsiveness to GH-releasing hormone, GH-releasing peptide-2 and thyrotrophin-releasing hormone in critical illness.
Van den Berghe G; de Zegher F; Bowers CY; Wouters P; Muller P; Soetens F; Vlasselaers D; Schetz M; Verwaest C; Lauwers P; Bouillon R
Clin Endocrinol (Oxf); 1996 Sep; 45(3):341-51. PubMed ID: 8949573
[TBL] [Abstract][Full Text] [Related]
16. Growth hormone-releasing peptides: clinical and basic aspects.
Argente J; García-Segura LM; Pozo J; Chowen JA
Horm Res; 1996; 46(4-5):155-9. PubMed ID: 8950613
[TBL] [Abstract][Full Text] [Related]
17. Leptin regulates growth hormone-releasing factor, somatostatin, and alpha-melanocyte-stimulating hormone but not neuropeptide Y release in rat hypothalamus in vivo: relation with growth hormone secretion.
Watanobe H; Habu S
J Neurosci; 2002 Jul; 22(14):6265-71. PubMed ID: 12122085
[TBL] [Abstract][Full Text] [Related]
18. Hexarelin modulates the expression of growth hormone secretagogue receptor type 1a mRNA at hypothalamic and pituitary sites.
Bresciani E; Nass R; Torsello A; Gaylinn B; Avallone R; Locatelli V; Thorner MO; Müller EE
Neuroendocrinology; 2004; 80(1):52-9. PubMed ID: 15361691
[TBL] [Abstract][Full Text] [Related]
19. Evidence that corticotropin-releasing hormone acts as a growth hormone-releasing factor in a primitive teleost, the European eel (Anguilla anguilla).
Rousseau K; Le Belle N; Marchelidon J; Dufour S
J Neuroendocrinol; 1999 May; 11(5):385-92. PubMed ID: 10320566
[TBL] [Abstract][Full Text] [Related]
20. Growth hormone (GH)-releasing hormone (GHRH) and the GH secretagogue (GHS), L692,585, differentially modulate rat pituitary GHS receptor and GHRH receptor messenger ribonucleic acid levels.
Kineman RD; Kamegai J; Frohman LA
Endocrinology; 1999 Aug; 140(8):3581-6. PubMed ID: 10433214
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]